metastatic colorectal cancer: trifluridine/tiripacil or regorafenib?
Published 7 years ago • 1.3K plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
0:58
managing colorectal cancer in patients who progress on regorafenib
-
2:36
prognostic value of metastatic sites in patients with mcrc treated with regorafenib
-
1:11
soregatt: sequencing regorafenib & trifluridine/tipiracil in pre-treated mcrc
-
12:47
debate: salvage therapy for mcrc? regorafenib followed by tas-102
-
3:23
trifluridine/tipiracil followed by regorafenib can be an effective treatment sequence in pretrea...
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
7:54
regorafenib vs tas-102 salvage therapy
-
3:39
impact of tas-102 in metastatic colorectal cancer - video abstract id 113320
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
0:43
onilon: trifluridine/tipiracil with nanoliposomal irinotecan in advanced crc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer
-
2:06
stivarga (regorafenib)- metastatic colorectal cancer
-
1:23
the rationale for combining regorafenib with io to treat patients with refractory mss-crc
-
11:36
panitumumab, regorafenib, and ziv-aflibercept in metastatic colorectal cancer